- Home
- IFRX vs ASYS Comparison
IFRX vs ASYS Comparison
Compare IFRX & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- ASYS
- Stock Information
- Founded
- IFRX 2007
- ASYS 1981
- Country
- IFRX Germany
- ASYS United States
- Employees
- IFRX N/A
- ASYS N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- ASYS Industrial Machinery/Components
- Sector
- IFRX Health Care
- ASYS Technology
- Exchange
- IFRX Nasdaq
- ASYS Nasdaq
- Market Cap
- IFRX 65.8M
- ASYS 70.3M
- IPO Year
- IFRX 2017
- ASYS N/A
- Fundamental
- Price
- IFRX $1.69
- ASYS $3.52
- Analyst Decision
- IFRX Strong Buy
- ASYS
- Analyst Count
- IFRX 4
- ASYS 0
- Target Price
- IFRX $8.50
- ASYS N/A
- AVG Volume (30 Days)
- IFRX 262.5K
- ASYS 72.4K
- Earning Date
- IFRX 05-07-2025
- ASYS 05-12-2025
- Dividend Yield
- IFRX N/A
- ASYS N/A
- EPS Growth
- IFRX N/A
- ASYS N/A
- EPS
- IFRX N/A
- ASYS N/A
- Revenue
- IFRX $140,242.00
- ASYS $90,826,000.00
- Revenue This Year
- IFRX $61.96
- ASYS N/A
- Revenue Next Year
- IFRX $80.59
- ASYS $31.66
- P/E Ratio
- IFRX N/A
- ASYS N/A
- Revenue Growth
- IFRX 30.90
- ASYS N/A
- 52 Week Low
- IFRX $0.82
- ASYS $3.20
- 52 Week High
- IFRX $2.82
- ASYS $6.96
- Technical
- Relative Strength Index (RSI)
- IFRX 62.40
- ASYS 42.14
- Support Level
- IFRX $1.53
- ASYS $3.26
- Resistance Level
- IFRX $1.92
- ASYS $3.59
- Average True Range (ATR)
- IFRX 0.19
- ASYS 0.18
- MACD
- IFRX 0.02
- ASYS 0.05
- Stochastic Oscillator
- IFRX 74.59
- ASYS 72.22
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.